Back to Journals » International Journal of Nanomedicine » Volume 18

131I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer

Total article views   HTML views PDF downloads Totals
3,994 Dovepress* 3,436+ 89 3,525
PubMed Central* 558 182 740
Totals 3,994 271 4,265
*Since 8 April 2023

View citations on PubMed Central and Google Scholar